# Efficient engineering of human and mouse primary cells using peptide-assisted genome editing
- Peptide-Assisted Genome Editing (PAGE)
- 这是一个可以降低基因编辑技术在进入细胞时的毒性的方法
- https://pubmed.ncbi.nlm.nih.gov/37095348/

# Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing
- 这是一个研究基因编辑的载体的研究，对于肺部
- 纳米
- https://pubmed.ncbi.nlm.nih.gov/36997680/

# Massively parallel base editing to map variant effects in human hematopoiesis
- 大规模平行编辑会导致造血障碍
- https://pubmed.ncbi.nlm.nih.gov/37137305/

# Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells
- 优化，减少临床 T 细胞染色体丢失
- https://pubmed.ncbi.nlm.nih.gov/37794590/

# Genome editing in cancer: Challenges and potential opportunities
- 在这里，我们将重点关注 CRISPR/Cas 9 系统固有的挑战，并讨论克服这些挑战的各种机会。
- https://pubmed.ncbi.nlm.nih.gov/36185740/

# Monocyte depletion enhances neutrophil influx and proneural to mesenchymal transition in glioblastoma
- 单核细胞耗竭增强胶质母细胞瘤中中性粒细胞流入和原神经向间质转化
- https://pubmed.ncbi.nlm.nih.gov/37012245/

# Genome editing and cancer therapy: handling the hypoxia-responsive pathway as a promising strategy
- 固体癌症微环境的特点是低氧水平
- https://pubmed.ncbi.nlm.nih.gov/37477829/

# Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival
- 通过 CRISPR/Cas 9 基因组编辑灭活结肠癌干细胞中的白细胞介素 30，抑制其致癌性并提高宿主存活率
- https://pubmed.ncbi.nlm.nih.gov/36927528/
